# SeedFolio

> SeedFolio is a VC fund in San Diego backing Health Care and Biotechnology. See 43 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Diego, United States
- Total investments: 43
- Last investment: Sep 2024
- Lead investor: 9%
- Last fund: Mar 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/seedfolio
- X (Twitter): https://twitter.com/seedfolio
- Website: https://www.seedfolio.vc

SeedFolio is a seed-stage venture capital firm investing in early-stage companies with a high potential of profitable impact in life sciences and resource efficiency.

## Contacts

5 contacts available for SeedFolio. Shizune tracks 1 team members at SeedFolio. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/seedfolio?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 16 | 37% |
| Biotechnology | 16 | 37% |
| Medical | 10 | 23% |
| Software | 6 | 14% |
| Medical Device | 5 | 12% |

60 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 38 | 88% |
| Series A | 1 | 2% |
| Funding Round | 1 | 2% |
| Venture - Series Unknown | 1 | 2% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 36 | 84% |
| Trinidad and Tobago | 2 | 5% |
| Canada | 1 | 2% |
| Denmark | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Joe Gatto | Managing Director | 5 | https://shizune.co/investors/profile/joe-gatto |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| HDAX Therapeutics | HDAX Therapeutics is pioneering next-gen precision therapeutics for cardiovascular and neurological diseases by targeting their root causes to enhance patient outcomes. | $3.2M | Seed | Sep 05, 2024 |  |
| VIAN Therapeutics | VIAN Therapeutics is an early-stage biotechnology company focused on transforming retinal disease treatment. With a first-in-class, non-invasive eyedrop as its lead product, VIAN aims to replace invasive injections for conditions like age-related macular degeneration (AMD) and diabetic macular edema (DME). Backed by strong preclinical data andongoing clinical testing, VIAN is positioned to address significant unmet medical needs and disrupt the $15 billion retinal disease market. | $1M | Seed | Jun 25, 2024 |  |
| Vasa Therapeutics | Vasa Therapeutics is a privately held, preclinical-stage encinitas, CA-based biopharmaceutical company. | $6M | Seed | Jan 03, 2024 |  |
| Eversun | Eversun is at the forefront of revolutionizing portable utility equipment, focusing on sustainability and innovation. Based in San Diego, Eversun has created the groundbreaking eTower, a comprehensive system that merges solar power, energy storage, communications, and lighting into a single, swiftly deployable unit.The eTower's unique designallows it to extend a telescopic mast up to 23 feet in under a minute, integrating LEDs, cameras, and data networks to offer seamless connectivity in any location. This makes it an invaluable asset for first responders, military units, disaster response teams, event organizers, and construction crews who require reliable power and communications on demand.What sets Eversun apart is its commitment to eco-friendliness and efficiency. The eTower is powered by renewable energy sources, primarily solar, backed by onboard lithium batteries, making it a sustainable alternative to traditional fuel-based power generators. This innovation significantly reduces greenhouse gas emissions and dependency on non-renewable energy sources.Founded by a team of entrepreneurs with expertise in network engineering, logistics, and sustainable energy, Eversun is driven by a mission to empower teams working in off-grid locations with innovative solutions. The eTower is not just a product; it's a step towards a future where remote site operations are sustainable, portable, and powered by solar energy. | $300K | Seed | Nov 22, 2023 |  |
| InProTher | InProTher is an immunotherapy company dedicated to developing the world’s first adaptive immune therapy capable of targeting immunosuppressive genes of ancient retroviruses. | $6.5M | Seed | May 24, 2023 |  |
| Trio Pharmaceuticals | Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California. | $2.2M | Seed | Mar 20, 2023 |  |
| Tiamat Sciences | Tiamat is a start-up producing affordable animal-free growth factors and biomolecules using plants as bioreactors. Thanks to its propriety platform, the company can manufacture a wide range of high-value proteins from antigens to growth factors.The company has already achieved a 10x cost reduction and at scale can get costs down 1000x even at 80%growth-margins, giving them a wide ability to price strategically. the coming years. The low investment needed to build a facility (up to 40x less than current solutions) combined with its unique technology makes Tiamat the ideal partner in production scale-up for promising markets that will soon become enormous such as cellular agriculture or cell & gene therapy. | $2M | Seed | Mar 09, 2023 |  |
| Duo Oncology | Duo Oncology develops a new nanoparticle technology specially tailored to penetrate established tumors.Duo Oncology operates as a lean pharma business. The company works hand-in-hand with world-class university scientists and medical oncologists to develop their products through a network of established research organizations with the greatestpossible speed and efficiency. | $3M | Seed | Feb 08, 2023 |  |
| Anvil Diagnostics | Anvil Diagnostics is a biotech research company which develops medicine for patients with sepsis. |  | Seed | Jan 01, 2023 |  |
| RecoverX | RecoverX develops computational evidence and safe AI technologies to augment medical decision-making and advance new medical evidence. |  | Seed | Jan 01, 2023 |  |

10 of 43 investments shown.

## Co-investors
- [Ulu Ventures](https://shizune.co/investors/profile/ulu-ventures) — VC Fund, 7 deals together
- [TCA Venture Group](https://shizune.co/investors/profile/tech-coast-angels) — VC Fund, 4 deals together
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 3 deals together
- [BioBrit](https://shizune.co/investors/profile/biobrit-llc) — VC Fund, 2 deals together
- [Casdin Capital](https://shizune.co/investors/profile/casdin-capital) — VC Fund, 2 deals together
- [FACIT](https://shizune.co/investors/profile/facit-prospects-oncology-fund) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund
- [Shell Ventures](https://shizune.co/investors/profile/shell-technology-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Clean Energy VC Funds in United States](https://shizune.co/investors/clean-energy-vc-funds-united-states)

## FAQ

### What does SeedFolio invest in?

SeedFolio invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 43 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact SeedFolio?

Public channels for SeedFolio include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SeedFolio?

The team at SeedFolio includes Joe Gatto (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co